Hematology NewsBiomarkers predict VTE risk with menopausal oral hormone therapyFebruary 6, 2019Thrombosis
Oncology PracticeImmunotherapy’s cardiac effects require early monitoring, managementFebruary 5, 2019Immuno-oncologyImmunotherapyThrombosisPatient & Survivor CareMelanomaLeukemia, Myelodysplasia, TransplantationALL
Hematology NewsImpaired clot lysis associated with mild bleeding symptomsJanuary 27, 2019ThrombosisMixed TopicsBleeding Disorders
Hematology NewsAnticoagulation shows promise in concurrent lupus nephritis, thrombotic microangiopathyJanuary 2, 2019Thrombosis
Hematology TimesFDA approves ravulizumab for PNHDecember 25, 2018AnemiaThrombosisPharmacyBleeding Disorders
Hematology NewsPhase 3 data support apixaban for cancer-associated VTEDecember 13, 2018Patient & Survivor CareThrombosis
Hematology NewsRivaroxaban may reduce VTE risk in cancer patientsDecember 6, 2018ThrombosisPatient & Survivor Care
Hematology NewsLarge cohort study IDs prognostic factors in thromboangiitis obliteransDecember 5, 2018Mixed TopicsThrombosis
Hematology NewsAVERT: Apixaban reduced thromboembolism risk in cancer patientsDecember 4, 2018ThrombosisPatient & Survivor Care
Hematology NewsDOAC pause yields favorable outcomes for AF patientsDecember 4, 2018ThrombosisBleeding Disorders
Hematology NewsEmapalumab safe, effective in pediatric primary hemophagocytic lymphohistiocytosisDecember 4, 2018ThrombosisPediatrics
